NCT06864130View on ClinicalTrials.gov

A Clinical Study on the Effect of Discontinuing Alendronate in Postmenopausal Women With Osteoporosis After a Treatment Period Without Fractures

PHASE4RecruitingINTERVENTIONAL
Enrollment

1,400

Participants

Timeline

Start Date

February 21, 2025

Primary Completion Date

March 1, 2029

Study Completion Date

September 15, 2029

Conditions
Osteoporosis in Post-menopausal Women
Interventions
DRUG

Alendronate 70mg weekly

The intervention is discontinuation of Alendronate

Trial Locations (7)

2400

NOT_YET_RECRUITING

Bispebjerg Hospital, Copenhagen

2650

NOT_YET_RECRUITING

Hvidovre Hospital, Hvidovre

2730

NOT_YET_RECRUITING

Copenhagen University Hospital (Herlev), Herlev

3400

NOT_YET_RECRUITING

Nordsjaellands Hospital (Hillerød), Hillerød

5000

RECRUITING

Odense University Hospital, Odense

6700

NOT_YET_RECRUITING

Esbjerg Og Grindsted Sygehus, Esbjerg

9000

NOT_YET_RECRUITING

Aalborg University Hospital, Aalborg

All Listed Sponsors
lead

Odense University Hospital

OTHER